Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
Elixiron Immunotherapeutics
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Company
Organization
Email Address
media@elixiron.com
Industry
Biology
Immunotherapy
Technology
Biopharmaceutical
Biotechnology
Investors
Pangu Venture Capital
DCI Partners
0
Latest Funding Round Date
August 23, 2021
LinkedIn URL
@company/elixiron-immunotherapeutics
Total Funding Amount (USD)
27,000,000
Official Website
elixiron.com
Find more companies like Elixiron Immunotherapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE